DOD Biotech Public Co., Ltd. (DOD) Stock Statistics & Valuation Metrics
Total Valuation
DOD Biotech Public Co., Ltd. has a market cap or net worth of THB 269.15M. The enterprise value is THB 534.82M.
- Market Cap
- THB 269.15M
- Enterprise Value
- THB 534.82M
Share Statistics
DOD Biotech Public Co., Ltd. has 434,118,160 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 434,118,160
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
DOD Biotech Public Co., Ltd.’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 2.58%.
- Return on Equity (ROE)
- 0.06
- Return on Assets (ROA)
- 0.05
- Return on Invested Capital (ROIC)
- 2.58%
- Return on Capital Employed (ROCE)
- 0.03
- Revenue Per Employee
- 2.36M
- Profits Per Employee
- 230.96K
- Employee Count
- 258
- Asset Turnover
- 0.53
- Inventory Turnover
- 3.56
Valuation Ratios
The current PE Ratio of DOD Biotech Public Co., Ltd. is 151.22. DOD Biotech Public Co., Ltd.’s PEG ratio is -1.57.
- PE Ratio
- 151.22
- PS Ratio
- 0.53
- PB Ratio
- 0.30
- Price to FCF
- -4.61
- Price to Operating Cash Flow
- -11.97
- PEG Ratio
- -1.57
Income Statement
In the last 12 months, DOD Biotech Public Co., Ltd. had revenue of 608.98M and earned 59.59M in profits. Earnings per share was 0.13.
- Revenue
- 608.98M
- Gross Profit
- 210.07M
- Operating Income
- 27.09M
- Pretax Income
- 43.45M
- Net Income
- 59.59M
- EBITDA
- 70.08M
- Earnings Per Share (EPS)
- 0.13
Cash Flow
In the last 12 months, operating cash flow was -22.95M and capital expenditures -37.69M, giving a free cash flow of -60.64M billion.
- Operating Cash Flow
- -22.95M
- Free Cash Flow
- -60.64M
- Free Cash Flow per Share
- -0.14
Dividends & Yields
DOD Biotech Public Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of 8.06%
- Dividend Per Share
- ―
- Dividend Yield
- 8.06%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -21.71%
- Earnings Yield
- 0.68%
Stock Price Statistics
- Beta
- 1.06
- 52-Week Price Change
- -64.37%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- 23.10
- Average Volume (3m)
- 578.97K
Important Dates
DOD Biotech Public Co., Ltd. upcoming earnings date is Feb 25, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 05, 2026
- Next Earnings Date
- Feb 25, 2027
- Ex-Dividend Date
- ―
Financial Position
DOD Biotech Public Co., Ltd. as a current ratio of 4.28, with Debt / Equity ratio of 7.34%
- Current Ratio
- 4.28
- Quick Ratio
- 3.32
- Debt to Market Cap
- 0.10
- Net Debt to EBITDA
- -0.84
- Interest Coverage Ratio
- 9.46
Taxes
In the past 12 months, DOD Biotech Public Co., Ltd. has paid -6.65M in taxes.
- Income Tax
- -6.65M
- Effective Tax Rate
- -0.15
Enterprise Valuation
DOD Biotech Public Co., Ltd. EV to EBITDA ratio is 6.87, with an EV/FCF ratio of -4.67.
- EV to Sales
- 0.54
- EV to EBITDA
- 6.87
- EV to Free Cash Flow
- -4.67
- EV to Operating Cash Flow
- -12.35
Balance Sheet
DOD Biotech Public Co., Ltd. has THB 59.47M in cash and marketable securities with THB 63.59M in debt, giving a net cash position of -THB 4.12M billion.
- Cash & Marketable Securities
- THB 59.47M
- Total Debt
- THB 63.59M
- Net Cash
- -THB 4.12M
- Net Cash Per Share
- -THB 0.01
- Tangible Book Value Per Share
- THB 1.99
Margins
Gross margin is 30.81%, with operating margin of -2.75%, and net profit margin of 0.35%.
- Gross Margin
- 30.81%
- Operating Margin
- -2.75%
- Pretax Margin
- -0.92%
- Net Profit Margin
- 0.35%
- EBITDA Margin
- 7.80%
- EBIT Margin
- -0.62%
Analyst Forecast
The average price target for DOD Biotech Public Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -17.88%
- EPS Growth Forecast
- -96.09%
